RxDoctor Payments Data

Travis Fitzke

Podiatrist · Fargo, NDNPI 1952966541

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (41.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Arthrex at 49.7% of the total. Reporting peaked in 2022 at $5,837 and has fallen 81.9% since, to $1,057 in 2025.

$8,721in general payments, 2019–2025

Across 82 payments — averaging $106.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$4K
  • Sioux Surgical Inc$3K
  • Stryker$554
  • Smith+Nephew$261
  • Organogenesis Inc.$105
  • Mimedx Group, Inc.$53
  • plus $162 from 6 others

What the payments were for

  • Travel & lodging$2,32227%
  • Food & beverage$2,79932%
  • Education$3,60041%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few podiatrist providers in North Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$82,581
Medicare patients
321
Services billed
1,298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam81$234
Oxycodone Hcl16$70
Gabapentin16$55

Paid to pharmacies, not to this prescriber.

Other podiatrist in Fargo

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →